Skip to main content

Vaccinations

Throughout the Covid-19 pandemic, B&M Care has been met with unprecedented challenges, but difficult circumstances have led to pockets of excellence across all areas of the business.

 

Update - April 2021

B&M Care is currently rolling out the second phase of the group's Covid-19 vaccination programme. Residents and staff from each of the group's 26 care homes will be offered the vaccination.

Re-visits will be coordinated to vaccinate individuals who were unable to receive the second dose of the vaccine when the initial visit within a home took place.


B&M Care's Covid-19 Vaccination Programme

The global introduction of approved coronavirus vaccines has been welcomed by a burst of optimism: a pivotal moment that looks set to best protecting our future.

In response to government guidelines, individuals living in a care home setting are a “top priority” for receiving the Covid-19 vaccination, in addition to those who administer their care.

Since the end of December, B&M Care began to roll out vaccines across the group with residents being vaccinated in their respective care homes. Staff are being vaccinated in either the home that they work in, or alternatively, at a local community vaccination hub.

Within two to three weeks of receiving the vaccine, individuals should have a significant degree of immunity to the virus.

B&M Care has not documented any significant adverse side effects.

In addition to the roll out of vaccinations, each B&M Care Home will continue to test residents on a monthly basis using PCR testing. Staff will continue to be tested weekly using PCR testing, as well as twice a week using Lateral Flow Device (LFD) test kits.

Should a resident or member of staff test positive using either test kit, additional testing is undertaken.


Covid-19 Vaccination & BAME Communities

Despite evidence that those in minority groups were hit hardest by the first wave of Covid-19 last spring, vaccination uptake rates among the black, Asian and minority ethnic (BAME) communities still remain markedly lower than other social demographics – and now having successfully completed the first phase of the group’s vaccination rollout, B&M Care has since documented similar disparities among staff and their respective backgrounds.

In-line with recognisable personalities, government and NHS officials attempting to dispel misinformation about both the virus and the vaccine, as the group moves into the second phase of its vaccination rollout, B&M Care is committed to positively engaging staff that represent BAME communities to reassure them about the efficacy and safety of the vaccination. Inclusivity will remain a key theme to continue provisioning the health, safety and wellbeing of those who live and work in each of our homes.


Vaccine Information

The ‘infodemic’ of Covid-19 misinformation remains as prevalent as the virus itself: a stream of speculative claims that continues to be spread through social media, texts and WhatsApp – with many falling prey to its content’s unfounded messaging. As a result, the rise-and-rise of fake news and ‘viral myths’ has cultivated questioning around the severity of Covid-19, which has subsequently now led to hesitancy and mistrust around the vaccination.

As a way of dispelling this modern misinformation, B&M Care has published a Vaccine Information Pack to further outline the efficacy and safety of the Covid-19 vaccination. Written by B&M Care’s Clinical Director, Dr Colleen Wood explains more about how vaccines work, as well as the three vaccinations currently approved for use in the UK. The pack also includes a dedicated FAQs section to build reassurance using factually accurate answers.